相关实验视频

Updated: Jul 13, 2026

Development of Antibiotic Resistance

Development of Antibiotic Resistance

Published on: June 12, 2025

整体素和NAFLD相关的肝病:临床关联,病理生理机制和药理影响

Yangyue Ni^1,2, Mengwen Huang^1,2, Shiyang Chen¹

¹Key Laboratory of Systems Health Science of Zhejiang Province, School of Life Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.

Acta biochimica et biophysica Sinica

|May 19, 2025

概括

非酒精性脂肪肝疾病 (NAFLD) 涉及炎症和整合素,细胞粘附分子对其进展至关重要. 向整合素对治疗NAFLD及其并发症如肝纤维化和相关癌症有很大的希望.

科学领域:

肝病学肝病学是一种肝病学.
免疫学免疫学免疫学
细胞生物学细胞生物学

背景情况:

非酒精性脂肪性肝病 (NAFLD) 是一个日益严重的全球健康问题,从简单的脂肪性肝炎到非酒精性脂肪性肝炎 (NASH),肝硬化和肝细胞癌 (HCC).
NAFLD的发病过程涉及比代谢功能障碍之外的复杂的炎症过程.
细胞粘附受体的整体素在NAFLD的发展和进展中发挥着关键作用.

研究的目的:

审查整合素在NAFLD病变发生过程中的多方面的作用.
在NAFLD的背景下探索综合介导下游信号通路.
总结目前针对NAFLD及其后果的整体蛋白的治疗策略.

主要方法:

综合蛋白和NAFLD研究的综合文献综述.
在肝细胞肥胖症,肝星细胞 (HSC) 激活和免疫细胞透中分析整合素功能.
对整合素向药物的临床和临床前数据的评估.

主要成果:

整合素与关键的NAFLD过程有关,包括肥胖症,HSC激活和免疫细胞招募.
综合素信号通路显著影响NAFLD的进展.
针对整合素的新兴药物显示出治疗NAFLD相关的脂肪酸,炎症,纤维化和HCC的潜力.

结论:

集成蛋白是NAFLD病原和进展的关键调节剂.
向整合素是一个有希望的治疗途径,用于管理NAFLD及其严重并发症.
为了有效治疗NAFLD,需要进一步研究整合素特异性疗法.

关键词:

这是NAFLD.与NAFLD相关的HCC是NAFLD相关的HCC.纳什·纳什 (Nash Nash) 是一个名为纳什的城市.诊断和治疗诊断和治疗整合物是一种整合物.

更多相关视频

Bacterial Phylum Spirochaetes

Bacterial Phylum Spirochaetes

Published on: June 12, 2025

Bacterial Phylum Actinobacteria

Bacterial Phylum Actinobacteria

Published on: June 6, 2025

相关概念视频

Chronic Pancreatitis I: Introduction

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...

Cirrhosis I: Introduction

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...

Cirrhosis II: Pathophysiology

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...

Chronic Pancreatitis I: Introduction

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...